- Home
- BBNX vs ACP Comparison
BBNX vs ACP Comparison
Compare BBNX & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | ACP |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 613.7M | 703.9M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBNX | ACP |
|---|---|---|
| Price | $13.85 | $5.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $27.58 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 337.9K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,570,000.00 | N/A |
| Revenue This Year | $53.88 | N/A |
| Revenue Next Year | $34.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.01 | N/A |
| 52 Week Low | $8.89 | $5.55 |
| 52 Week High | $32.71 | $7.17 |
Technical Indicators
Market Signals| Indicator | BBNX | ACP |
|---|---|---|
| Relative Strength Index (RSI) | 33.99 | 63.70 |
| Support Level | $13.25 | $5.64 |
| Resistance Level | $15.53 | $5.72 |
| Average True Range (ATR) | 0.99 | 0.05 |
| MACD | 0.47 | 0.00 |
| Stochastic Oscillator | 46.10 | 93.75 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.